1.
Nervenarzt
; 71(12): 927-8, 2000 Dec.
Artigo
em Alemão
| MEDLINE
| ID: mdl-11139987
Assuntos
Baclofeno/uso terapêutico , Toxinas Botulínicas Tipo A/uso terapêutico , Clonidina/análogos & derivados , Clonidina/uso terapêutico , Relaxantes Musculares Centrais/uso terapêutico , Espasticidade Muscular/tratamento farmacológico , Animais , Baclofeno/efeitos adversos , Toxinas Botulínicas Tipo A/efeitos adversos , Clonidina/efeitos adversos , Indústria Farmacêutica , Humanos , Injeções Espinhais , Relaxantes Musculares Centrais/efeitos adversos , Espasticidade Muscular/etiologia , Receptores Adrenérgicos alfa 2/efeitos dos fármacos , Receptores de GABA-B/efeitos dos fármacos , Pesquisa
2.
Arch Ophthalmol
; 101(9): 1447-9, 1983 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-6615314
RESUMO
Glaucomatous damage develops in certain patients because of elevated episcleral venous pressure (EVP). To measure the EVP in typical clinical settings, a practical and reliable instrument is needed. We have developed such an instrument, the venomanometer, and present tests of its reproducibility. The intraobserver reproducibility was 0.7 mm Hg, and the mean difference between the readings of two observers was 0.7 +/- 1.2 mm Hg. We then used the venomanometer to study the EVP in 122 eyes of 68 normal subjects distributed in seven age groups between 10 and 80 years. The EVP did not vary with age (mean, 7.6 +/- 1.3 mm Hg). This value is compared with those obtained with other instruments.